tiprankstipranks
Trending News
More News >
Safety Shot (SHOT)
NASDAQ:SHOT
US Market
Advertisement

Safety Shot (SHOT) AI Stock Analysis

Compare
877 Followers

Top Page

SH

Safety Shot

(NASDAQ:SHOT)

Rating:51Neutral
Price Target:
$0.50
▲(0.00%Upside)
The overall stock score of 51 reflects a balance between severe financial difficulties and potential positive impacts from recent corporate events. While technical indicators show slight positive momentum, the weak financial performance and poor valuation weigh heavily on the score.

Safety Shot (SHOT) vs. SPDR S&P 500 ETF (SPY)

Safety Shot Business Overview & Revenue Model

Company DescriptionSafety Shot, Inc., a wellness and functional beverage company, researches and develops over-the-counter products and intellectual property. The company offers Safety Shot Beverage, an over-the-counter drink that lowers blood alcohol content. It also develops Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women's sexual wellness; and NoStingz, a jellyfish sting prevention sunscreen. The company sells its products through distributors, retailers, and e-commerce websites. The company was formerly known as Jupiter Wellness, Inc. and changed its name to Safety Shot, Inc. in September 2023. Safety Shot, Inc. was incorporated in 2018 and is based in Jupiter, Florida.
How the Company Makes MoneySafety Shot makes money through the direct sale of its Safety Shot beverage to consumers via retail and online channels. The company partners with various retailers and e-commerce platforms to distribute its products widely, ensuring accessibility to a broad customer base. Additionally, Safety Shot may engage in strategic partnerships with nightlife establishments, events, and promotional campaigns to boost product visibility and sales. These revenue streams, combined with targeted marketing efforts, contribute to the company's earnings.

Safety Shot Financial Statement Overview

Summary
Safety Shot's financial performance is weak, with declining revenues, negative profit margins, and a heavily leveraged balance sheet. Ongoing operational losses and significant cash flow issues highlight the company's financial instability and reliance on external funding.
Income Statement
40
Negative
Safety Shot's income statement reveals a challenging financial situation. The company has experienced declining total revenue from 2022 to the TTM period, with a significant drop from 2022's $6.2 million to TTM's $1.0 million. Gross profit margins are negative, indicating the cost of goods sold exceeds revenues. Net profit margins are deeply negative, with TTM net income at -$39.1 million. The company has negative EBIT and EBITDA margins, highlighting ongoing operational losses. Revenue growth is negative, reflecting declining sales performance.
Balance Sheet
30
Negative
The balance sheet presents a weak financial position. The debt-to-equity ratio is not interpretable due to negative stockholders' equity, indicating potential insolvency risks. Total liabilities exceed total assets, leading to a negative equity situation in the TTM period. This reflects financial instability and a heavily leveraged position. The company has a negative equity ratio, which is concerning for investors. The trend of increasing liabilities relative to declining equity suggests deteriorating financial health.
Cash Flow
35
Negative
Cash flow analysis highlights significant cash management issues. Operating cash flow is consistently negative, with TTM figures at -$17.3 million, indicating the company is not generating enough cash from operations. Free cash flow is also negative, suggesting insufficient cash to cover capital expenditures. The operating cash flow to net income ratio and free cash flow to net income ratio are both concerning, indicating cash flow challenges and a reliance on external financing to sustain operations.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue701.97K202.67K6.20M2.88M1.07M
Gross Profit-2.45M-74.46K1.03M535.49K441.10K
EBITDA-47.81M-12.19M-15.29M-26.18M-6.01M
Net Income-49.41M-15.08M-15.22M-28.10M-6.29M
Balance Sheet
Total Assets7.34M12.71M8.69M18.87M6.53M
Cash, Cash Equivalents and Short-Term Investments631.54K5.33M4.85M14.66M4.26M
Total Debt5.63M2.07M2.73M861.61K1.33M
Total Liabilities9.51M3.89M5.03M2.27M2.13M
Stockholders Equity-2.17M8.82M3.67M16.60M4.39M
Cash Flow
Free Cash Flow-19.17M-10.22M-6.41M-7.81M-2.78M
Operating Cash Flow-19.09M-10.11M-6.40M-7.57M-2.73M
Investing Cash Flow-4.94K-330.05K-2.47M-13.15M-245.99K
Financing Cash Flow15.61M12.80M-955.56K28.21M6.71M

Safety Shot Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.50
Price Trends
50DMA
0.36
Positive
100DMA
0.41
Positive
200DMA
0.62
Negative
Market Momentum
MACD
0.04
Negative
RSI
61.66
Neutral
STOCH
57.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SHOT, the sentiment is Positive. The current price of 0.5 is above the 20-day moving average (MA) of 0.39, above the 50-day MA of 0.36, and below the 200-day MA of 0.62, indicating a neutral trend. The MACD of 0.04 indicates Negative momentum. The RSI at 61.66 is Neutral, neither overbought nor oversold. The STOCH value of 57.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SHOT.

Safety Shot Risk Analysis

Safety Shot disclosed 46 risk factors in its most recent earnings report. Safety Shot reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Safety Shot Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
$2.22B38.4724.86%8.01%11.26%
75
Outperform
$3.25B12.1523.07%5.13%13.22%11.37%
65
Neutral
CHF27.11B20.009.37%3.35%35.94%-1.97%
57
Neutral
$448.02M-85.68%4.56%57.03%
54
Neutral
$226.37M-28.87%-6.83%19.09%
51
Neutral
$55.93M-1514.12%-61.03%5.63%
39
Underperform
$50.78M-117.82%22.04%-21.72%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SHOT
Safety Shot
0.50
-0.60
-54.55%
AKO.A
Embotelladora Andina SA
18.85
5.30
39.11%
BRFH
Barfresh Food Group
3.19
-0.73
-18.62%
OTLY
Oatly Group
14.97
-7.23
-32.57%
ZVIA
Zevia PBC
3.05
2.27
291.03%
COCO
Vita Coco Company
39.16
13.41
52.08%

Safety Shot Corporate Events

Private Placements and FinancingBusiness Operations and Strategy
Safety Shot Enters Stock Purchase Agreement
Neutral
Jul 17, 2025

On July 14, 2025, Safety Shot, Inc. entered into a stock purchase agreement with an institutional investor, selling 500,000 shares of SRM Entertainment, Inc. common stock for $2,500,000. This transaction could impact the company’s financial position and market strategy by providing additional capital and potentially altering its investment portfolio.

Delistings and Listing ChangesPrivate Placements and FinancingBusiness Operations and StrategyRegulatory Filings and Compliance
Safety Shot Sells SRM Shares in Strategic Move
Neutral
Jul 15, 2025

On July 11, 2025, Safety Shot, Inc. entered into a stock purchase agreement with an institutional investor, selling 500,000 shares of SRM Entertainment, Inc. common stock for $3,125,000. This transaction is part of the company’s strategic financial maneuvers. Earlier in the year, on January 2, 2025, Safety Shot received a notice from Nasdaq regarding non-compliance with the minimum bid price requirement. However, on July 9, 2025, Nasdaq granted the company an extension until December 29, 2025, to regain compliance, with plans to consider a reverse stock split if necessary to meet the listing requirements.

Private Placements and FinancingBusiness Operations and Strategy
Safety Shot Secures Capital Through Share Sale
Neutral
Jul 9, 2025

On July 3, 2025, Safety Shot, Inc. entered into a Securities Purchase Agreement with an accredited investor for the sale of 844,594 shares, generating gross proceeds of $250,000 at a discounted price of $0.296 per share. This agreement reflects a strategic financial maneuver by Safety Shot, Inc., potentially impacting its market positioning by securing additional capital through this discounted share offering.

Private Placements and FinancingBusiness Operations and StrategyRegulatory Filings and Compliance
Safety Shot Amends Securities Purchase Agreement
Positive
Jul 9, 2025

On July 2, 2025, Safety Shot, Inc. amended its Securities Purchase Agreement with two accredited investors, reducing the exercise price of warrants from $0.4348 to $0.33 per share. The company also entered into an Exchange Agreement to facilitate a voluntary security exchange transaction involving convertible notes and Series B Preferred Stock. This move, along with the filing of a Certificate of Designation for Series B Convertible Preferred Stock, which outlines rights and preferences such as voting rights and conversion terms, aims to enhance the company’s financial structure and market positioning.

Private Placements and FinancingBusiness Operations and Strategy
Safety Shot Secures Investment, Alters Equity Structure
Positive
Jul 2, 2025

On June 30, 2025, Safety Shot, Inc. entered into a Securities Purchase Agreement with an accredited investor for the purchase of 1,000,000 shares at a discounted price, raising $250,000. This move reflects the company’s strategic financial maneuvers to strengthen its capital position. Additionally, on the same date, the company completed an exchange agreement with Core 4 Capital Corp., resulting in the cancellation of over 6.5 million common stock shares in exchange for Series A-1 Preferred Stock, indicating a shift in its equity structure.

M&A TransactionsBusiness Operations and Strategy
Safety Shot Completes Acquisition of Yerbaé Brands Corp.
Positive
Jun 27, 2025

On June 27, 2025, Safety Shot, Inc. completed its acquisition of Yerbaé Brands Corp. through a court-approved plan of arrangement. The transaction resulted in Safety Shot shareholders owning approximately 81.64% of the combined company, while former Yerbaé shareholders hold about 18.36%. The acquisition is expected to enhance Safety Shot’s market position by integrating Yerbaé’s plant-based energy beverages with its wellness product line, potentially broadening its customer base and strengthening its industry presence.

Private Placements and Financing
Safety Shot Enters Securities Purchase Agreement
Neutral
Jun 23, 2025

On June 18, 2025, Safety Shot, Inc. entered into a Securities Purchase Agreement with an accredited investor to sell 1,157,407 shares for $250,000 at a price of $0.216 per share. This agreement is part of the company’s efforts to manage its financial obligations. Additionally, on June 16, 2025, Safety Shot issued 7,275,915 shares of Common Stock to Silverback Capital Corporation as part of a liabilities settlement program, settling $1,461,800 of its outstanding liabilities, which originally totaled $14,580,395.73.

M&A TransactionsBusiness Operations and Strategy
Safety Shot Nears Completion of Yerbaé Acquisition
Positive
Jun 20, 2025

On June 20, 2025, Safety Shot, Inc. announced an update on the expected closing of its acquisition of Yerbaé Brands Corp., a plant-based functional beverage company. Following stockholder approval on June 12, 2025, the final administrative steps are being completed, with the closing now anticipated next week. This acquisition is expected to enhance Safety Shot’s market positioning by integrating Yerbaé’s zero-sugar, zero-calorie energy beverages into its portfolio, appealing to health-conscious consumers.

Private Placements and FinancingShareholder MeetingsStock SplitBusiness Operations and Strategy
Safety Shot Shareholders Approve Key Proposals
Neutral
Jun 16, 2025

On June 12, 2025, Safety Shot, Inc. held a special meeting where shareholders approved several key proposals, including an amendment to the 2024 Equity Incentive Plan to increase the number of shares by up to 22,000,000. Additionally, shareholders authorized the issuance of shares to Yerbaé Shareholders and Core 4 Capital Corp., as well as the issuance of promissory notes and a potential reverse stock split. These decisions reflect strategic moves to enhance the company’s financial flexibility and align with Nasdaq listing requirements, potentially impacting its market positioning and stakeholder interests.

M&A TransactionsShareholder Meetings
Safety Shot Shareholders Approve Yerbaé Acquisition
Positive
Jun 13, 2025

On June 13, 2025, Safety Shot, Inc. announced that its shareholders have approved the acquisition of Yerbaé Brands Corp., a plant-based functional beverage company. The merger, expected to finalize next week, will see the combined entity continue under the Safety Shot name with its stock trading on Nasdaq. This strategic acquisition aims to leverage Yerbaé’s distribution network to enhance growth in the functional beverage market, combining Safety Shot’s wellness products with Yerbaé’s energy beverages.

Private Placements and FinancingLegal Proceedings
Safety Shot Amends Settlement Agreement with Silverback
Neutral
Jun 4, 2025

Safety Shot, Inc., a Delaware corporation, has entered into a liabilities settlement program with Silverback Capital Corporation to manage its debts by issuing freely trading securities. On May 20, 2025, court approval was granted for this program, and on May 29, 2025, the company amended the settlement agreement to adjust terms such as the closing price, valuation period, and minimum price floor, while also issuing 1,000,000 shares to SCC as consideration for legal and transaction fees.

Product-Related AnnouncementsBusiness Operations and Strategy
Safety Shot Expands into Nootropics and Sleep Aid Markets
Positive
Jun 3, 2025

On June 3, 2025, Safety Shot, Inc. announced the initiation of research and development for new product lines targeting the nootropics and sleep aid markets. This strategic expansion leverages the company’s expertise from its Sure Shot™ product to create innovative solutions aimed at cognitive enhancement and restorative sleep. The development phase is underway, with prototypes expected later this year, positioning Safety Shot to potentially gain substantial market share in these rapidly growing sectors.

Shareholder MeetingsStock Split
Safety Shot Announces Virtual Annual Shareholders’ Meeting
Neutral
May 29, 2025

On May 29, 2025, Safety Shot, Inc. announced its upcoming virtual Annual Shareholders’ Meeting scheduled for June 12, 2025. Shareholders are encouraged to vote on several proposals, including share issuance, an incentive plan amendment, and a reverse stock split, which could impact the company’s market strategy and compliance with Nasdaq rules.

M&A TransactionsBusiness Operations and Strategy
Safety Shot Expands Reach with Yerbaé Partnership
Positive
May 28, 2025

On May 27, 2025, Safety Shot, Inc. announced that its acquisition partner, Yerbaé Brands Corp., has entered into a strategic partnership with Guckenheimer, a national food service operator. This collaboration will expand Yerbaé’s distribution of functional beverages across Guckenheimer’s 480 locations in 34 states, enhancing its presence in corporate dining and potentially broadening Safety Shot’s reach in the food and beverage sector.

Private Placements and FinancingLegal Proceedings
Safety Shot’s Liabilities Settlement Program Approved
Neutral
May 27, 2025

Safety Shot has entered into a liabilities settlement program with Silverback Capital Corporation, allowing it to pay down its debts by issuing freely trading securities. The program, which was subject to court approval, received the necessary approval on May 20, 2025, potentially impacting the company’s financial stability and stakeholder interests.

M&A TransactionsBusiness Operations and Strategy
Safety Shot Acquires Yerbae Brands to Boost Revenue
Positive
May 23, 2025

On May 23, 2025, Safety Shot, Inc. announced its acquisition of Yerbae Brands Corp., aiming to leverage Yerbae’s strong retail presence and distributor network to significantly boost its market position and revenue. The acquisition is expected to increase Safety Shot’s annual revenue by 1000% over 2024, enhancing shareholder value and expanding the company’s reach in the functional beverage market.

Private Placements and Financing
Safety Shot Secures Funding Through Share Sale Agreement
Positive
May 15, 2025

On May 9, 2025, Safety Shot, Inc. entered into a Securities Purchase Agreement with an accredited investor for the sale of 641,000 shares, generating gross proceeds of $250,000 at a price of $0.39 per share. This transaction reflects Safety Shot’s efforts to secure additional funding, potentially impacting its financial stability and market positioning.

Private Placements and FinancingRegulatory Filings and Compliance
Safety Shot Enters Exchange Agreement with Core 4 Capital
Neutral
May 7, 2025

On May 2, 2025, Safety Shot, Inc. entered into an Exchange Agreement with Core 4 Capital Corp., involving the exchange of common stock and warrants for Series A Preferred Stock. This agreement includes lock-up provisions preventing Core 4 from transferring the shares for at least six months. The company also filed a Certificate of Designation for the Series A Preferred Stock, detailing rights such as dividends, voting rights, and conversion options, which may impact the company’s equity structure and shareholder dynamics.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 17, 2025